Gallium-67
Ga-67 · Gallium, Z = 31, A = 67
Gallium-67 (Ga-67) carries 2.21e+16 Bq/g, or 5.98e+5 Ci/g: a gigabecquerel is 45.2 ng, no weighable quantity at all. It decays by electron capture with a half-life of 3.2617 days, which leaves 22.59% of today's activity after a week and 4.0e-7% after three months.
At 0.0189 mGy·m²/(GBq·h) the air kerma rate constant is 4.1× less than Cs-137 and 16× less than Co-60, placing it 54 of 96 photon emitters in this dataset.
The two columns of the line table disagree here: the 300.2 keV line carries the largest share of the dose rate although the 184.6 keV line is emitted more often — energy, not frequency, decides which photons set the shield.
A half-value layer of 0.656 mm in lead puts this in foil and thin sheet, with 5.36 mm needed if the material is steel; ten-fold attenuation comes at 4.28 mm of lead. At 1 GBq and a metre it is already under 20 µSv/h with nothing in the way. The tenth-value layer runs 6.5 times the half-value layer, not the 3.32 a single energy would give.
Ga-67 for imaging infection, inflammation and lymphoma
Ga-67 citrate was for decades a standard scintigraphy agent for finding infection, inflammation and lymphoma, its gallium travelling in the blood on the iron-binding sites of transferrin. Its tumour use was found by accident, when gallium citrate tried as a bone-scanning agent in cancer patients showed uptake in lymph nodes involved by Hodgkin's disease. It has been displaced in many centres by white-cell labelling and by PET, but it is still used where those are unavailable and is preferred to labelled white cells for spinal disc infection.
Cyclotrons make it from zinc targets, and it is supplied as a citrate solution ready for injection. Ga-66, made in the same targets, has far harder photons but a shorter half-life, so its share falls between production and use. The daughter Zn-67 is stable, so no ingrowth needs allowing for. The zinc level behind the softest main line has a half-life of some microseconds, so that line is emitted well after the photons that feed its level. That transition also emits a conversion electron nearly as often as a photon.
Three medium-soft lines, with a weaker, harder fourth, share the dose rate, and gamma cameras image them with a medium-energy collimator using two or three windows at once; the lead layer on this page is modest. The softest window is usually dropped in very obese patients and within a day or so of a Tc-99m injection. The decay is electron capture, so there is no beta, and the patient's dose comes from the photons and from the conversion and Auger electrons released close to the decay site.
Its half-life allows imaging a day or more after injection, and clinic waste can be stored for a few weeks to decay. In syringe and vial shields, roughly a millimetre of lead removes the softest line and most of the second, leaving the two harder ones, so shielding ample for Tc-99m passes a noticeable gallium dose rate. Gallium is cleared slowly through the gut, which is why bowel activity complicates the images. It collects in the lactating breast too, so breastfeeding is suspended for weeks or stopped. Haemolysis or repeated transfusion, by saturating transferrin, alters where it goes, as does treatment with the iron-chelating drug desferrioxamine.
Half-life, specific activity and dose rate
| Half-life | 3.2617 days (2.818e+5 s) |
| Decay mode | electron capture |
| Specific activity | 2.21e+16 Bq/g (5.98e+5 Ci/g) |
| Air kerma rate constant Γ (δ = 20 keV) | 0.0189 mGy·m²/(GBq·h) |
| Dose rate, 1 GBq at 1 m | 0.0189 mGy/h |
| Dose rate, 1 Ci at 1 m | 0.699 mGy/h |
| Kerma-weighted mean photon energy | 241.4 keV |
10 lines above the cutoff, and what each contributes
4 further lines below the 20 keV cutoff, the highest at 9.61 keV and 59.6% emission probability in all, are excluded here and from Γ. Probability and dose share.
| Energy (keV) | Emission probability (%) | Share of dose rate (%) |
|---|---|---|
| 300.22 | 16.64 | 34.85 |
| 184.58 | 21.41 | 25.16 |
| 93.31 | 38.81 | 20.67 |
| 393.53 | 4.56 | 12.83 |
| 208.95 | 2.46 | 3.36 |
| 91.27 | 3.11 | 1.63 |
| 887.69 | 0.148 | 0.91 |
| 794.38 | 0.054 | 0.30 |
| 494.17 | 0.0684 | 0.24 |
| 703.11 | 0.0105 | 0.05 |
0.656 mm of lead halves this spectrum
Solved numerically across all 10 lines, narrow beam. Why not one representative energy.
| Material | HVL (mm) | TVL (mm) | TVL / HVL |
|---|---|---|---|
| lead | 0.656 | 4.28 | 6.52 |
| tungsten | 0.484 | 3.10 | 6.39 |
| iron | 5.36 | 22.1 | 4.12 |
| copper | 4.35 | 18.8 | 4.33 |
| concrete | 23.6 | 81.6 | 3.46 |
| water | 51.9 | 177 | 3.41 |
| aluminum | 20.9 | 72.8 | 3.48 |
A single energy would give 3.32. Spectrum and attenuation ratios.
Activity over days and weeks
Ten half-lives is 32.6 days — for Ga-67 itself, a storage problem rather than a disposal one, since those ten half-lives already take it below 0.1% of today's activity. The mean life 1/λ is 4.71 days.
| Elapsed | Fraction remaining |
|---|---|
| 1 half-life | 50.0 % |
| 2 half-lives | 25.0 % |
| 5 half-lives | 3.13 % |
| 10 half-lives | 0.0977 % |
| Time to fall to 10 % of today's activity | 10.8 days |
| Time to fall to 1 % | 21.7 days |
| Time to fall to 0.1 % | 32.5 days |
Limits of these dose rates
- Air kerma, 1 µGy counted as 1 µSv — not H*(10).
- Model limits and internal dose.
Gamma and decay calculators for Ga-67
Other Gallium nuclides: Ga-68
Computed from the IAEA Nuclear Data Section — Livechart API (ENSDF) and the NIST X-Ray Mass Attenuation Coefficients. Derivations and citations.